Physical Therapists in Cleveland Hts, OH Accepting Medicare
5 Physical Therapists found. Showing 1 - 5
 Melissa Ann Miozzi, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5 Serverance Circle, Ste 115, Cleveland Hts, OH 44118 Phone: 216-381-0300 Fax: 216-896-0825 |
Miss Trixie Bernardo Paraiso, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2680 Euclid Heights Blvd, Apt 203-e, Cleveland Hts, OH 44106 Phone: 216-632-2116 |
 Joseph Moskowitz Pt Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 3803 Severn Rd, Cleveland Hts, OH 44118 Phone: 216-577-1933 Fax: 216-342-1141 |
 Mr. Mark Jester Enal Gloriani, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2680 Euclid Heights Blvd, Apt203e, Cleveland Hts, OH 44106 Phone: 216-632-2117 |
Jennifer L Occkial, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5 Severance Cir, Suite 10, Cleveland Hts, OH 44118 Phone: 216-896-0824 Fax: 216-896-0825 |
News Archive
PCSG campaign highlights significance of family doctors in early gastroenterological cancer diagnosis
With cancer survival rates in the UK persistently trailing comparable European countries, it's time to admit to a national problem – and do something about it, says a leading expert at the Primary Care Society for Gastroenterology.
Express Diagnostics Int'l announces start of operations at new subsidiary in Bulgaria
Express Diagnostics Int'l, Inc., FDA-registered and ISO 13485:2003-certified medical device manufacturer, announces Express Diagnostics Global, Ltd., a new subsidiary based in Sofia, Bulgaria is operational.
Electroclinical triggers for repeat MRI in intractable epilepsy identified
Researchers have outlined the electroclinical features typically associated with bottom-of-sulcus dysplasia, the surgical removal of which often cures epilepsy in affected patients.
FDA provides feedback on the pending NDA for EXALGO tablets
CombinatoRx, Incorporated and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced that on November 13, 2009, representatives of Neuromed discussed the pending New Drug Application (NDA) for the product candidate EXALGOTM (hydromorphone HCl extended release) tablets, seeking FDA approval for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time, with staff from the United States Food and Drug Administration (FDA).
› Verified 8 days ago
Physical Therapists
Podiatrists
Occupational Therapists
Speech-Language Pathologists